NEWS & PRESS RELEASES
Milan, 2005 - breaking news

Pregabalin - the successor of Gabapentin

Further to the introduction of the Italian Bolar Roche, Labochim, one of the leaders in the production of Gabapentin, gave a boost to its R&D activity, introducing several new projects in its pipe-line.

In this frame, Labochim has recently accomplished the R&D phase of Pregabalin, a 3-substituted analogue of gamma-amino butyric acid (GABA), which is seen as the successor of Gabapentin.

Samples and further information for R&D purposes only, are available on request.